-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Entero Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2023.
- Entero Therapeutics, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$9.23M, a 127% decline year-over-year.
- Entero Therapeutics, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$20.9M, a 184% decline year-over-year.
- Entero Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$15.8M, a 24.4% decline from 2022.
- Entero Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$12.7M, a 78.5% increase from 2021.
- Entero Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$59.1M, a 123% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)